Candesartan prevents L-NAME-induced cardio-renal injury in spontaneously hypertensive rats beyond hypotensive effects
Our goal was to assess the cardiovascular and renal protection afforded by angiotensin II type 1-receptor blockade against NG-nitro-L-arginine methyl ester (L-NAME)-exacerbated hypertension in young spontaneously hypertensive rats (SHR), in comparison with the antihypertensive drug, hydralazine. Mal...
Main Authors: | Daniel Casellas, Abderraouf Herizi, Annie Artuso, Albert Mimran, Bernard Jover |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi - SAGE Publishing
2001-03-01
|
Series: | Journal of the Renin-Angiotensin-Aldosterone System |
Online Access: | https://doi.org/10.1177/14703203010020011501 |
Similar Items
-
Candesartan in treating hypertension
by: L O Minushkina
Published: (2014-03-01) -
Cardio classics revisited – focus on the role of candesartan
by: Maria Leonarda De Rosa
Published: (2010-11-01) -
Blood pressure-independent effect of candesartan on cardio-ankle vascular index in hypertensive patients with metabolic syndrome
by: Kanako Bokuda, et al.
Published: (2010-07-01) -
Persistent effect of treatment with candesartan cilexetil on blood pressure in spontaneously hypertensive rats
by: Karin Skov, et al.
Published: (2001-03-01) -
Morphological changes in tissues of organs in rats with arterial hypertension (SHR) with treatment of hypotensive medicines (with ramipril and candesartan) in combination with corvitin
by: Alena Marushchak, et al.
Published: (2020-02-01)